MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers

被引：11

作者：

Luo, Fanyan ^{[1
,2
]}

Liu, Wei ^{[1
,2
]}

Bu, Haisong ^{[1
,2
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Surg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China

来源：

HEART FAILURE REVIEWS | 2022年 / 27卷 / 06期

关键词：

MicroRNAs; Hypertrophic cardiomyopathy; Pathogenesis; Biomarkers; Diagnosis; Treatment; SEE VOL. 292; CARDIAC-HYPERTROPHY; CARDIOVASCULAR-DISEASE; ANIMAL-MODEL; REPRESSION; APOPTOSIS; PATHWAY; DYSREGULATION; THERAPEUTICS; DEFICIENCY;

D O I：

10.1007/s10741-022-10231-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy and is characterized by increased left ventricular wall thickness, but existing diagnostic and treatment approaches face limitations. MicroRNAs (miRNAs) are type of noncoding RNA molecule that plays crucial roles in the pathological process of cardiac remodelling. Accordingly, miRNAs related to HCM may represent potential novel therapeutic targets. In this review, we first discuss the different roles of miRNAs in the development of HCM. We then summarize the roles of common miRNAs as diagnostic and clinical biomarkers in HCM. Finally, we outline current and future challenges and potential new directions for miRNA-based therapeutics for HCM.

引用

页码：2211 / 2221

页数：11

共 98 条

[1] MicroRNAs Are Necessary for Vascular Smooth Muscle Growth, Differentiation, and Function [J].

Albinsson, Sebastian ;

Suarez, Yajaira ;

Skoura, Athanasia ;

Offermanns, Stefan ;

Miano, Joseph M. ;

Sessa, William C. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (06) :1118-U80

[2] MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art [J].

Angelopoulos, Andreas ;

Oikonomou, Evangelos ;

Vogiatzi, Georgia ;

Antonopoulos, Alexios ;

Tsalamandris, Sotirios ;

Georgakopoulos, Christos ;

Papanikolaou, Paraskevi ;

Lazaros, George ;

Charalambous, Georgios ;

Siasos, Gerasimos ;

Vlachopoulos, Charalambos ;

Tousoulis, Dimitris .

CURRENT MEDICINAL CHEMISTRY, 2021, 28 (36) :7400-7412

[3] 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (vol 142, e558, 2020) [J].

Ommen .

CIRCULATION, 2020, 142 (25) :e633-e633

[4] Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure [J].

Bagnall, Richard D. ;

Tsoutsman, Tatiana ;

Shephard, Rhian E. ;

Ritchie, William ;

Semsarian, Christopher .

PLOS ONE, 2012, 7 (09)

[5] Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy [J].

Bang, Claudia ;

Batkai, Sandor ;

Dangwal, Seema ;

Gupta, Shashi Kumar ;

Foinquinos, Ariana ;

Holzmann, Angelika ;

Just, Annette ;

Remke, Janet ;

Zimmer, Karina ;

Zeug, Andre ;

Ponimaskin, Evgeni ;

Schmiedl, Andreas ;

Yin, Xiaoke ;

Mayr, Manuel ;

Halder, Rashi ;

Fischer, Andre ;

Engelhardt, Stefan ;

Wei, Yuanyuan ;

Schober, Andreas ;

Fiedler, Jan ;

Thum, Thomas .

JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (05) :2136-2146

[6]

Baptista PV, 2014, NANOMEDICINE-UK, V9, P2247, DOI [10.2217/nnm.14.143, 10.2217/NNM.14.143]

[7] CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure [J].

Batkai, Sandor ;

Genschel, Celina ;

Viereck, Janika ;

Rump, Steffen ;

Baer, Christian ;

Borchert, Tobias ;

Traxler, Denise ;

Riesenhuber, Martin ;

Spannbauer, Andreas ;

Lukovic, Dominika ;

Zlabinger, Katrin ;

Hasimbegovic, Ena ;

Winkler, Johannes ;

Garamvolgyi, Rita ;

Neitzel, Sonja ;

Gyoengyoesi, Mariann ;

Thum, Thomas .

EUROPEAN HEART JOURNAL, 2021, 42 (02) :192-201

[8] Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy [J].

Bernardo, Bianca C. ;

Nguyen, Sally S. ;

Winbanks, Catherine E. ;

Gao, Xiao-Ming ;

Boey, Esther J. H. ;

Tham, Yow Keat ;

Kiriazis, Helen ;

Ooi, Jenny Y. Y. ;

Porrello, Enzo R. ;

Igoor, Sindhu ;

Thomas, Colleen J. ;

Gregorevic, Paul ;

Lin, Ruby C. Y. ;

Du, Xiao-Jun ;

McMullen, Julie R. .

FASEB JOURNAL, 2014, 28 (12) :5097-5110

[9] The two TORCs and Akt [J].

Bhaskar, Prashanth T. ;

Hay, Nissim .

DEVELOPMENTAL CELL, 2007, 12 (04) :487-502

[10] MicroRNAs in Atrial Fibrillation [J].

Briasoulis, Alexandros ;

Sharma, Shikha ;

Telila, Tesfaniye ;

Mallikethi-Reddy, Sagar ;

Papageorgiou, Nikolaos ;

Oikonomou, Evangelos ;

Tousoulis, Dimitris .

CURRENT MEDICINAL CHEMISTRY, 2019, 26 (05) :855-863

← 1 2 3 4 5 6 7 8 9 10 →